Denali Therapeutics Inc. (DNLI) › Total LiabilitiesDenali Therapeutics Inc. (DNLI) — Total LiabilitiesAnnual figures by period end, from SEC filings.2017-12-31: $20.93M2018-12-31: $115.14M2019-12-31: $158.34M2020-12-31: $453.75M2021-12-31: $441.87M2022-12-31: $417.81M2023-12-31: $122.96M2024-12-31: $144.50M2025-12-31: $131.09M$131.09M2017-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$131.09M-9.3%2026-02-26Balance as of period end2024-12-31$144.50M+17.5%2026-02-26Balance as of period end2023-12-31$122.96M-70.6%2025-02-27Balance as of period end2022-12-31$417.81M-5.4%2024-02-28Balance as of period end2021-12-31$441.87M-2.6%2023-02-27Balance as of period end2020-12-31$453.75M+186.6%2022-02-28Balance as of period end2019-12-31$158.34M+37.5%2021-02-26Balance as of period end2018-12-31$115.14M+450.2%2020-02-27Balance as of period end2017-12-31$20.93M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)